Approval · Notice of Compliance 17412 · 2015
CAYSTON: Notice of Compliance 17412
Issued October 16, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17412
- Date
- October 16, 2015
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To propose alternate container closure system component (flip tear off seal) for drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAYSTON | Not yet assigned | — |
Medicinal ingredients
- AZTREONAM 75 MG per VIAL